Ciampelli C, Galleri G, Galioto M, Mereu P, Pirastru M, Bernardoni R
Int J Mol Sci. 2025; 26(5).
PMID: 40076730
PMC: 11900240.
DOI: 10.3390/ijms26052093.
Tang M, Liu Y, Hu Z, Luo H, Zhang S, Shi C
Front Aging Neurosci. 2025; 16:1454735.
PMID: 40012862
PMC: 11861300.
DOI: 10.3389/fnagi.2024.1454735.
Huang T, Sun C, Du F, Chen Z
Proc Natl Acad Sci U S A. 2025; 122(8):e2415422122.
PMID: 39982740
PMC: 11874320.
DOI: 10.1073/pnas.2415422122.
Hegde A, Timm L, Sivley C, Ramiyaramcharankarthic S, Lowrimore O, Hendrix B
Int J Mol Sci. 2025; 26(3).
PMID: 39940735
PMC: 11817509.
DOI: 10.3390/ijms26030966.
Bagnoli E, Lin Y, Burel S, Jaimon E, Antico O, Themistokleous C
Proc Natl Acad Sci U S A. 2025; 122(5):e2412029122.
PMID: 39874296
PMC: 11804522.
DOI: 10.1073/pnas.2412029122.
A STING-CASM-GABARAP pathway activates LRRK2 at lysosomes.
Bentley-DeSousa A, Roczniak-Ferguson A, Ferguson S
J Cell Biol. 2025; 224(2.
PMID: 39812709
PMC: 11734622.
DOI: 10.1083/jcb.202310150.
Widespread Distribution of α-Synuclein Oligomers in -related Parkinson's Disease.
Sekiya H, Franke L, Hashimoto Y, Takata M, Nishida K, Futamura N
bioRxiv. 2025; .
PMID: 39764048
PMC: 11702646.
DOI: 10.1101/2024.12.18.629265.
The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson's disease.
Bai X, Zhu J, Chen Y, Sun H
Future Med Chem. 2024; 17(2):221-236.
PMID: 39717965
PMC: 11749465.
DOI: 10.1080/17568919.2024.2444875.
Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism.
Gilsbach B, Ho F, Riebenbauer B, Zhang X, Guaitoli G, Kortholt A
Elife. 2024; 12.
PMID: 39699947
PMC: 11658767.
DOI: 10.7554/eLife.91083.
Molecular dynamics studies reveal the structural impacts of LRRK2 R1441C and LRRK2 D1994A mutations in Parkinson's disease.
Rahman R, Zaman B, Islam M, Rashid M
Biochem Biophys Rep. 2024; 40:101866.
PMID: 39610832
PMC: 11603123.
DOI: 10.1016/j.bbrep.2024.101866.
Single cell long read whole genome sequencing reveals somatic transposon activity in human brain.
Izydorczyk M, Kalef-Ezra E, Horner D, Zheng X, Holmes N, Toffoli M
medRxiv. 2024; .
PMID: 39606404
PMC: 11601780.
DOI: 10.1101/2024.11.11.24317113.
Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson's disease risk.
Chew E, Liu Z, Li Z, Chung S, Lian M, Tandiono M
Nat Aging. 2024; 5(2):205-218.
PMID: 39572736
PMC: 11839463.
DOI: 10.1038/s43587-024-00760-7.
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2.
Raig N, Surridge K, Sanz-Murillo M, Dederer V, Kramer A, Schwalm M
bioRxiv. 2024; .
PMID: 39554022
PMC: 11565912.
DOI: 10.1101/2024.09.17.613365.
The potential of exosomal biomarkers: Revolutionizing Parkinson's disease: How do they influence pathogenesis, diagnosis, and therapeutic strategies?.
Akbari-Gharalari N, Ghahremani-Nasab M, Naderi R, Chodari L, Nezhadshahmohammad F
AIMS Neurosci. 2024; 11(3):374-397.
PMID: 39431275
PMC: 11486621.
DOI: 10.3934/Neuroscience.2024023.
Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration.
Cui X, Li X, Zheng H, Su Y, Zhang S, Li M
NPJ Parkinsons Dis. 2024; 10(1):189.
PMID: 39428415
PMC: 11491477.
DOI: 10.1038/s41531-024-00799-8.
A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson's Disease: An Updated Patent and Clinical Trials.
Khan S, Haider M
CNS Neurol Disord Drug Targets. 2024; 24(3):181-195.
PMID: 39400019
DOI: 10.2174/0118715273323074241001071645.
The p.L1795F variant causes Parkinson's disease in the European population.
Lange L, Levine K, Fox S, Marras C, Ahmed N, Kuznetsov N
Res Sq. 2024; .
PMID: 39372927
PMC: 11451652.
DOI: 10.21203/rs.3.rs-4772543/v1.
MicroRNAs regulation in Parkinson's disease, and their potential role as diagnostic and therapeutic targets.
Shaheen N, Shaheen A, Osama M, Nashwan A, Bharmauria V, Flouty O
NPJ Parkinsons Dis. 2024; 10(1):186.
PMID: 39369002
PMC: 11455891.
DOI: 10.1038/s41531-024-00791-2.
Primary cilia in Parkinson's disease: summative roles in signaling pathways, genes, defective mitochondrial function, and substantia nigra dopaminergic neurons.
Tian Z, Zhang Y, Xu J, Yang Q, Hu D, Feng J
Front Aging Neurosci. 2024; 16:1451655.
PMID: 39364348
PMC: 11447156.
DOI: 10.3389/fnagi.2024.1451655.
RAB12-LRRK2 complex suppresses primary ciliogenesis and regulates centrosome homeostasis in astrocytes.
Li X, Zhu H, Huang B, Li X, Kim H, Tan H
Nat Commun. 2024; 15(1):8434.
PMID: 39343966
PMC: 11439917.
DOI: 10.1038/s41467-024-52723-6.